GB0808326D0 - Compositions and methods for the treatment of fybromyalgia - Google Patents

Compositions and methods for the treatment of fybromyalgia

Info

Publication number
GB0808326D0
GB0808326D0 GBGB0808326.3A GB0808326A GB0808326D0 GB 0808326 D0 GB0808326 D0 GB 0808326D0 GB 0808326 A GB0808326 A GB 0808326A GB 0808326 D0 GB0808326 D0 GB 0808326D0
Authority
GB
United Kingdom
Prior art keywords
fybromyalgia
compositions
treatment
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0808326.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
E Therapeutics PLC
Original Assignee
E Therapeutics PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by E Therapeutics PLC filed Critical E Therapeutics PLC
Priority to GBGB0808326.3A priority Critical patent/GB0808326D0/en
Publication of GB0808326D0 publication Critical patent/GB0808326D0/en
Priority to PCT/GB2009/001161 priority patent/WO2009136176A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0808326.3A 2008-05-08 2008-05-08 Compositions and methods for the treatment of fybromyalgia Ceased GB0808326D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0808326.3A GB0808326D0 (en) 2008-05-08 2008-05-08 Compositions and methods for the treatment of fybromyalgia
PCT/GB2009/001161 WO2009136176A1 (en) 2008-05-08 2009-05-08 Compositions and methods for the treatment of fibromyalgia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0808326.3A GB0808326D0 (en) 2008-05-08 2008-05-08 Compositions and methods for the treatment of fybromyalgia

Publications (1)

Publication Number Publication Date
GB0808326D0 true GB0808326D0 (en) 2008-06-18

Family

ID=39570964

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0808326.3A Ceased GB0808326D0 (en) 2008-05-08 2008-05-08 Compositions and methods for the treatment of fybromyalgia

Country Status (2)

Country Link
GB (1) GB0808326D0 (en)
WO (1) WO2009136176A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20200206220A1 (en) * 2017-05-12 2020-07-02 The Hong Kong University Of Science And Technology Heterocyclic compounds as epha4 inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3304361A1 (en) * 1982-02-17 1983-08-25 Sandoz-Patent-GmbH, 7850 Lörrach MOTHER CORNAL CALOIDS, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS
DE102004035978A1 (en) * 2004-07-23 2006-03-16 Justus-Liebig-Universität Giessen New aminoadamantane derivatives useful for treating e.g. viral diseases, Parkinson's disease, Huntington's chorea, Alzheimer's disease, autism, tinnitus, Tourette syndrome, hypertension, sleep disorders and psychosis
US7619007B2 (en) * 2004-11-23 2009-11-17 Adamas Pharmaceuticals, Inc. Method and composition for administering an NMDA receptor antagonist to a subject
JP2006321743A (en) * 2005-05-18 2006-11-30 Taisho Pharmaceut Co Ltd Sleep-ameliorating agent

Also Published As

Publication number Publication date
WO2009136176A1 (en) 2009-11-12

Similar Documents

Publication Publication Date Title
EP2361089A4 (en) Compositions and methods for the treatment of altered -synuclein function
HK1250393A1 (en) Methods and compositions for the detection and treatment of preeclampsia
HK1159498A1 (en) Methods and compositions for the treatment of cancer
IL206970A0 (en) Compositions and methods for the treatment of tumor of hematopoietic origin
PL3208612T3 (en) Compositions and methods for the treatment of immune related diseases
IL210810A0 (en) Compositions for the treatment of pain and/or inflamtion
IL202015A0 (en) Methods and compositions for treating skin conditions
EP2331123A4 (en) Compositions and methods for the treatment of hepatitis c
ZA201006648B (en) Methods of treatment
HK1146894A1 (en) Compositions and methods for treating diseases of the nail
HK1166305A1 (en) Compositions and methods for the treatment of inflammation
EP2340027A4 (en) Methods and compositions for the treatment of cancer
IL210097A0 (en) Compositions and methods for treating unfluenza
IL210997A0 (en) Compositions for the treatment of mrsa and uses thereof
GB0718446D0 (en) Compositions and methods for the treatment of infection
EP2429584A4 (en) Methods and compositions for treatment
IL196843A0 (en) Compositions and methods for the treatment of radiation proctosigmoitis
EP2249789A4 (en) Compositions and methods for the treatment of xerostomia
IL214349A0 (en) Compositions and methods for the treatment of cancer
HK1211472A1 (en) Compositions and methods of treatment comprising ceftaroline
EP2437738A4 (en) Methods and compositions for the treatment of cancer
EP2150270A4 (en) Methods and compositions for the treatment of cancer
EP2285398A4 (en) Methods and compositions for the treatment of obesity
EP2142566A4 (en) Methods and compositions for the treatment of proliferative diseases
EP2411031A4 (en) Methods and compositions for the treatment of cancer

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)